Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II)-Reference-Cited by-同舟云学术

Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II)

Published:2020-08 Issue: Volume:226 Page:222-231
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Berry Natalia,Mauri Laura,Feldman Ted,Komtebedde Jan,van Veldhuisen Dirk J.,Solomon Scott D.,Massaro Joseph M.,Shah Sanjiv J.

Funder

Corvia Medical, Inc

Corvia Medical

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Heart failure: preventing disease and death worldwide;Ponikowski;ESC Heart Fail,2014

2. Heart disease and stroke statistics—2017 update: a report from the American Heart Association;Benjamin;Circulation,2017

3. The emerging epidemic of heart failure with preserved ejection fraction;Oktay;Curr Heart Fail Rep,2013

4. Heart failure with preserved ejection fraction;Gladden;Pflugers Arch,2014

5. Heart failure with preserved ejection fraction;Redfield;N Engl J Med,2016

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF;JACC: Heart Failure;2024-08

2. Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction;JAMA Cardiology;2024-06-01

3. Heart Failure with Preserved Ejection Fraction: The Pathophysiological Mechanisms behind the Clinical Phenotypes and the Therapeutic Approach;International Journal of Molecular Sciences;2024-01-08

4. (The effect of an inter-atrial communication in the treatment of the patients with heart failure with mildly reduced and preserved ejection fraction - current state of knowledge);Cor et Vasa;2023-12-22

5. Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP‐HF II trial;European Journal of Heart Failure;2023-12-07